quinoxalines has been researched along with Ambulation Disorders, Neurologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leung, LS; Ma, J | 1 |
1 other study(ies) available for quinoxalines and Ambulation Disorders, Neurologic
Article | Year |
---|---|
The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.
Topics: Acoustic Stimulation; Animals; Behavior, Animal; Dizocilpine Maleate; Electroencephalography; Excitatory Amino Acid Antagonists; GABA Agonists; Gait; Gait Disorders, Neurologic; Hippocampus; Ketamine; Locomotion; Male; Mammillary Bodies; Muscimol; Neural Pathways; Quinoxalines; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Septal Nuclei; Time Factors | 2007 |